About Virocan Therapeutics Private Limited
Data last updated:
Virocan Therapeutics Private Limited is a private limited company based in Guntur, Andhra Pradesh, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 18 August 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24239AP2005PTC047169.
The company has an authorised share capital of ₹49 Lakh and a paid-up capital of ₹49 Lakh. It is led by directors including Donald Willard Weaver and Jose Edson Silva Pontes.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Guntur, Andhra Pradesh.
The company is associated with 1 brand: Virocan Therapeutics.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website virocan.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressNH – 5 Edulapalem, Prathipadu, Guntur, Andhra Pradesh, India – 522019
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Virocan Therapeutics Private Limited
Virocan Therapeutics operates one associated brand: Virocan Therapeutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Biotechnology research and drug discovery focused on cancer and related diseases. | virocan.com |
Financials of Virocan Therapeutics Private Limited FY 2025 filings available
Financial Statement Summary of Virocan Therapeutics Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Virocan Therapeutics Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Virocan Therapeutics are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Virocan Therapeutics Private Limited
Virocan Therapeutics has 4 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Donald Willard Weaver | Director | 16 Apr 2012 | 14 Years 6 Months | Current |
| Jose Edson Silva Pontes | Director | 20 Jul 2014 | 12 Years 3 Months | Current |
| Sreenivasa Rao Batchu Also directs: BRD Agro Products Private Limited | Director | 21 Aug 2025 | 1 Years 2 Months | Current |
| Rajesh Dachepalli Also directs: Dayspring Therapeutics Private Limited | Manager | 25 Sep 2013 | 13 Years 0 Months | Current |
Ownership and Shareholding of Virocan Therapeutics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Virocan Therapeutics Private Limited
Virocan Therapeutics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Virocan Therapeutics Private Limited
Employment history and EPFO contributions of people linked to Virocan Therapeutics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Virocan Therapeutics Private Limited
Virocan Therapeutics Private Limited has 15 board changes on record since 2012: 4 appointments and 11 cessations. The latest: Sreenivasa Rao Batchu was appointed as Director on 21 Aug 2025.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Virocan Therapeutics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Virocan Therapeutics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Virocan Therapeutics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Virocan Therapeutics Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Virocan Therapeutics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Virocan Therapeutics Private Limited
Virocan Therapeutics is an active private limited company based in Guntur, Andhra Pradesh, India. The company works in chemical products, within the chemicals industry. It was incorporated on 18 August 2005 (21+ years old) and is registered under CIN U24239AP2005PTC047169.
Virocan Therapeutics has 4 current directors:
- Donald Willard Weaver - Director
- Jose Edson Silva Pontes - Director
- Sreenivasa Rao Batchu - Director
- Rajesh Dachepalli - Manager
The CIN (Corporate Identification Number) of Virocan Therapeutics is U24239AP2005PTC047169. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Virocan Therapeutics was incorporated on 18 August 2005, making it 21+ years old. It is registered with the Registrar of Companies, Vijayawada.
Sreenivasa Rao Batchu was appointed as Director on 21 Aug 2025. David Ellis ceased to be Director on 28 Mar 2019. Kambhampati Laxmi Kantha Rao ceased to be Director on 14 Sep 2018. Virocan Therapeutics has 15 board changes on record in total.
Virocan Therapeutics can be reached through the website virocan.com. Its registered office is in Guntur, Andhra Pradesh, India.
The registered office of Virocan Therapeutics is at NH – 5 Edulapalem, Prathipadu, Guntur, Andhra Pradesh, India – 522019.
Virocan Therapeutics has an authorised share capital of ₹49 Lakh and a paid-up capital of ₹49 Lakh.
Virocan Therapeutics operates in the chemicals industry, in the chemical products segment.
No. Virocan Therapeutics is not listed on any stock exchange. It is an unlisted company.